3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
9
Terminated
2
Active not recruiting
2
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
16
Myelodysplastic Syndromes
12
Multiple Myeloma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Hematologic Neoplasms
6
Neuroblastoma
5
Hodgkin Disease
5
Retinoblastoma
4
Lymphoma, Non-Hodgkin
4
Graft vs Host Disease
4
Anemia, Refractory, with Excess of Blasts
4
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Recurrence
2
Primary Myelofibrosis
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Leukemia
2
Ganglioneuroblastoma
2
Anemia, Aplastic
2
beta-Thalassemia
1
Venentoclax
1
Thrombocythemia, Essential
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Interventions
pembrolizumab
38
Blood Specimen Collection
38
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
17
Exercise
17
Carboplatin
17
Nivolumab
15
atezolizumab
14
Paclitaxel
14
Cisplatin
14
Drug Therapy
13
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
11
Trastuzumab
10
Pemetrexed
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Melphalan
×
Clear all
NCT05477589
2024-12-19
SCRIPT-AML
Vastra Gotaland Region
Phase 3
Recruiting
170 enrolled